From a purely pathological perspective, our data strongly suggest that AD might follow distinct molecular courses in the male and female brain, with differences paralleling changes in depression-related monoamine systems and risk being influenced differently by 5-HTTLPR length polymorphisms and APOE ε4 allele status. This evidence concerns the gene APOE and depressive symptom measurement.